Why Invest

Profitable specialty pharmaceutical company with a diversified portfolio 

Cipher’s lean operating structure and collaborative approach to commercialization and development enable rapid and efficient scaling while maximizing our profitability.

  • Solid dermatology platform
  • Established presence across the Americas
  • Strong balance sheet
  • History of positive operating cash flow
  • Robust pipeline
  • Proven leadership team

Download Investor Presentation

Latest News
Sep 5, 2023

Cipher Pharmaceuticals Inc. (TSX: CPH) ("Cipher" or "the Company"), is announcing its intention to commence a substantial issuer bid (the "Offer" or "SIB") pursuant to which the Company will offer...

Aug 10, 2023

(All figures are presented in U.S. dollars) Strong growth capital available with $36.3 million in cash and cash equivalents Net income increased by 32% year-over-year to $5.7 million EPS increased...

Jul 28, 2023

Cipher Pharmaceuticals Inc. (TSX: CPH) ("Cipher" or "the Company") today announced that it will release its financial results for the second quarter of 2023 on Thursday, August 10, 2023. The...

More News >

Latest Event
IR Contact

Annual Reports

Quarterly Reports